awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38567540-219ED8E6-D3E3-4D00-B219-90C005FC2B9D
Q38567540-219ED8E6-D3E3-4D00-B219-90C005FC2B9D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38567540-219ED8E6-D3E3-4D00-B219-90C005FC2B9D
Setting Appropriate Goals for the Next Generation of Clinical Trials in Myelofibrosis.
P2860
Q38567540-219ED8E6-D3E3-4D00-B219-90C005FC2B9D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38567540-219ED8E6-D3E3-4D00-B219-90C005FC2B9D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
efeb6022f7132f20baa136677f93e71233d2d03f
P2860
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis.